5 news items
HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $10 Price Target
ACET
5 Jun 24
HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
ACET
5 Jun 24
," "potential," "predict," "project," "should," "target," "would" and similar expressions are intended to identify forward-looking statements, although
HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $10 Price Target
ACET
15 May 24
HC Wainwright & Co. analyst Edward White reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
ACET
14 May 24
therapy candidate targeting CD70+ cancers, in multiple CD70+ solid and hematological tumor indications. Based on ADI-270's promising profile
HC Wainwright & Co. Maintains Buy on Adicet Bio, Maintains $10 Price Target
ACET
2 Apr 24
HC Wainwright & Co. analyst Edward White maintains Adicet Bio (NASDAQ:ACET) with a Buy and maintains $10 price target.
- Prev
- 1
- Next